Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.

Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, Kronenberg F, Marcelli D, Passlick-Deetjen J, Schernthaner G, Fouqueray B, Wheeler DC; ARO Investigators.

Nephrol Dial Transplant. 2011 Jun;26(6):1948-55. doi: 10.1093/ndt/gfq219. Epub 2010 Apr 25.

2.

Vitamin D compounds for people with chronic kidney disease not requiring dialysis.

Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD008175. doi: 10.1002/14651858.CD008175. Review.

PMID:
19821446
3.

Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis.

Natoli JL, Boer R, Nathanson BH, Miller RM, Chiroli S, Goodman WG, Belozeroff V.

BMC Nephrol. 2013 Apr 17;14:88. doi: 10.1186/1471-2369-14-88. Review.

4.

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.

Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF.

JAMA. 2011 Mar 16;305(11):1119-27. doi: 10.1001/jama.2011.308. Review.

PMID:
21406649
5.

Evaluation of anemia and serum iPTH, calcium, and phosphorus in patients with primary glomerulonephritis.

Li Y, Zhang W, Ren H, Wang W, Shi H, Li X, Chen X, Shen P, Wu X, Xie J, Chen N.

Contrib Nephrol. 2013;181:31-40. doi: 10.1159/000348636. Epub 2013 May 8. Review.

PMID:
23689565
6.

Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies.

Da J, Xie X, Wolf M, Disthabanchong S, Wang J, Zha Y, Lv J, Zhang L, Wang H.

Am J Kidney Dis. 2015 Aug;66(2):258-65. doi: 10.1053/j.ajkd.2015.01.009. Epub 2015 Mar 21. Review.

PMID:
25804679

Supplemental Content

Support Center